BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, March 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 6, 2001
View Archived Issues
Additional study needed to support transdermal methylphenidate NDA
Read More
Antex Biologics reports major progress in clinical development programs over past year
Read More
Novogyne acquires CombiPatch
Read More
OraPharma launches Arestin in the U.S. for adjunctive treatment of periodontal disease
Read More
Sustained-release naltrexone enters phase II in alcohol-dependent patients
Read More
Discovery Laboratories begins phase III IRDS trial for Surfaxin
Read More
Demegen completes next step in Periodontix acquisition
Read More
ACS news: design and synthesis of novel beta3-adrenoceptor agonists reported by Wyeth-Ayerst
Read More
PTI-801, a new drug candidate for chronic pain, enters development at Pain Therapeutics
Read More
Integrin antagonists as orally active tumor angiogenesis inhibitors subject of ACS presentation
Read More
Sangamo and Onyx to codevelop novel cancer therapeutics
Read More
First-in-class indolocarbazole anticancer agent introduced by BMS at ACS and AACR meetings
Read More
FDA begins review of Ortec's CCS product for burn patients
Read More
U.K. investigators report promising preclinical data for telomerase inhibitors
Read More
Second-line antihypertensive combination therapy launched in U.S.
Read More
DuPont seeks FDA approval for new formulation of Sustiva
Read More
Analogues of p38 MAP kinase inhibitor RPR-200765A with improved profile obtained at Aventis
Read More
AstraZeneca begins phase III evaluation of platinum anticancer agent; milestone triggered
Read More
J-115814 exerts anorexigenic effects by blocking Y1 receptors
Read More
Identification of a small molecule targeting CDK4 with promise for treating tumors
Read More
Novel compounds useful as JNK inhibitors patented by Vertex
Read More
Positive decision issued in Europe for Reductil obesity treatment
Read More
Antitumor isophosphoramide mustard analogues designed at Southern Research Institute
Read More
Italian researchers identify new indazolamides with utility particularly in IBS
Read More
Potent, broad-spectrum antiviral activity demonstrated by Maruishi compounds
Read More
Selective sigma2 receptor ligands patented by Santen
Read More
Tularik's arylsulfonanilide derivatives useful as pharmacologically active agents
Read More
Metalloproteinase inhibitors from Pfizer for inflammation, cancer, etc.
Read More
Newly issued patent covers thymidylate synthase inhibitors synthesized at SUNY
Read More
